Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues

Mitochondrial damage is a hallmark of metabolic diseases, including diabetes, yet the consequences of compromised mitochondria in metabolic tissues are often unclear. In this work, we report that dysfunctional mitochondrial quality control engages a retrograde (mitonuclear) signaling program that impairs cellular identity and maturity in β cells, hepatocytes, and brown adipocytes. Targeted deficiency throughout the mitochondrial quality control pathway, including genome integrity, dynamics, or turnover, impaired the oxidative phosphorylation machinery, activating the mitochondrial integrated stress response, eliciting chromatin remodeling, and promoting cellular immaturity rather than apoptosis to yield metabolic dysfunction. Pharmacologic blockade of the integrated stress response in vivo restored β cell identity after the loss of mitochondrial quality control. Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-02-06
DOI
https://doi.org/10.1126/science.adf2034
Citations
48
Primary Topic
Mitochondrial Function and Pathology
Type
article
Field-Weighted Citation Impact
37.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues

Aaron Renberg, Tracy Stromer, Benjamin Thompson, Leena Haataja et al.
48 citations
Science
Mitochondrial Function and Pathology
37.88
article

Retrograde mitochondrial signaling governs the identity and maturity of metabolic tissues

Aaron Renberg, Tracy Stromer, Benjamin Thompson, Leena Haataja, Anne Lietzke, Irina X. Zhang, Emily M. Walker, Gemma L. Pearson, Vaibhav Sidarala, Scott A. Soleimanpour, Stephen C.J. Parker, Elena Levi-D’Ancona, Jin Li, Sarah A. Ware, Leslie S. Satin, Peter Arvan, Brett A. Kaufman, Lori Sussel, Michael L. Stitzel, Nathan Lawlor, Deqiang Zhang, Emma C. Reck, Kawthar Mohamed, Nathan Qi, Vishal S. Parekh, Dre L. Hubers, Ava M. Stendahl, Lei Yin, Jie Zhu, Mabelle B. Pasmooij
article en
48 citations

Abstract

Mitochondrial damage is a hallmark of metabolic diseases, including diabetes, yet the consequences of compromised mitochondria in metabolic tissues are often unclear. In this work, we report that dysfunctional mitochondrial quality control engages a retrograde (mitonuclear) signaling program that impairs cellular identity and maturity in β cells, hepatocytes, and brown adipocytes. Targeted deficiency throughout the mitochondrial quality control pathway, including genome integrity, dynamics, or turnover, impaired the oxidative phosphorylation machinery, activating the mitochondrial integrated stress response, eliciting chromatin remodeling, and promoting cellular immaturity rather than apoptosis to yield metabolic dysfunction. Pharmacologic blockade of the integrated stress response in vivo restored β cell identity after the loss of mitochondrial quality control. Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders.

ScienceVol. 388(6743)
University of Pittsburgh (US), University of Michigan (US), VA Ann Arbor Healthcare System (US), Michigan Medicine (US), Jackson Laboratory (US), University of Colorado Anschutz Medical Campus (US), UConn Health (US)
Good health and well-being
Openalex Percentile: Top 0%
Mitochondrial Function and Pathology
37.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.